ICAD 2.13 (+12.7%)
US44934S2068• Healthcare Providers & Services• Health Information Services
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. ICAD

Icad (ICAD) Competitor Comparison

We are evaluating the key criteria listed to compare Icad (ICAD) against its competitors in the Health Information Services industry.

Market Capitalization

30 / 35

Gross Profits

29 / 31

Total Revenue

31 / 33

EBITDA

23 / 33

Free Cashflow

24 / 34

Quick Ratio

19 / 34

Earnings per Share

15 / 33

Dividend yield

0 / 3

Total Cash

31 / 34

Performance 3 years

24 / 35

Performance 5 years

23 / 35

Performance 10 years

26 / 35

Linearity 3 years

26 / 35

Linearity 5 years

18 / 35

Linearity 10 years

22 / 35

Total Rank

15 / 35

Dividend Rank

3 / 35

Valuation Rank

25 / 35

Piotroski Rank

32 / 35

Muliplier Rank

9 / 35

Valuation Rank - ICAD ranking 25 / 35

These are the competitors of Icad in the industry Health Information Services ranked by valuation rank
1. Teladoc Health TDOC
0.79
2. Sophia Genetics SOPH
0.79
3. Change Healthcare CHNG
0.79
4. Accolade ACCD
0.71
5. CareMax CMAX
0.71
6. Allscripts Healthcare Solutions MDRX
0.71
7. GoodRx Holdings GDRX
0.71
8. 1Life Healthcare ONEM
0.71
9. Tabula Rasa HealthCare TRHC
0.71
10. Forian FORA
0.64
11. CareCloud MTBC
0.64
12. Omnicell OMCL
0.64
13. Augmedix AUGX
0.64
14. Covetrus CVET
0.64
15. Agiliti AGTI
0.64
16. Privia Health Group PRVA
0.64
17. Evolent Health EVH
0.57
18. SomaLogic SLGC
0.57
19. Definitive Healthcare DH
0.57
20. Doximity DOCS
0.57
21. Premier Inc PINC
0.57
22. ZHONGCHAO ZCMD
0.57
23. iCoreConnect ICCT
0.57
24. NextGen Healthcare NXGN
0.57
25. icad ICAD
0.5
26. 10x Genomics TXG
0.5
27. Phreesia PHR
0.5
28. Progyny PGNY
0.5
29. Veeva Systems VEEV
0.5
30. Signify Health SGFY
0.43
31. HeartBeam BEAT
0.43
32. Simulations Plus SLP
0.43
33. OptimizeRx OPRX
0.36
34. Healthcare Triangle HQY
0.36
35. NantHealth NH
0.29
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.